UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Active smoking and the risk of estrogen receptor‐positive and triple‐negative breast cancer among women ages 20 to 44 years

Cancer, 2014-04, Vol.120 (7), p.1026-1034

2014

Volltextzugriff (PDF)

Relationship Between Potentially Modifiable Lifestyle Factors and Risk of Second Primary Contralateral Breast Cancer Among Women Diagnosed With Estrogen Receptor–Positive Invasive Breast Cancer

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5312-5318

2009

Volltextzugriff (PDF)

Height, body mass index (BMI), BMI change, and the risk of estrogen receptor‐positive, HER2‐positive, and triple‐negative breast cancer among women ages 20 to 44 years

Cancer, 2014-05, Vol.120 (10), p.1548-1556

2014

Volltextzugriff (PDF)

Disparities in Risk of Advanced-Stage Liver Cancer and Mortality by Race and Ethnicity

JNCI : Journal of the National Cancer Institute, 2022-09, Vol.114 (9), p.1238-1245

2022

Volltextzugriff (PDF)

Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer

Cancer epidemiology, biomarkers & prevention, 2024-02, Vol.33 (2), p.288-297

2024

Volltextzugriff (PDF)

Relationship between Diabetes and Diabetes Medications and Risk of Different Molecular Subtypes of Breast Cancer

Cancer epidemiology, biomarkers & prevention, 2019-11, Vol.28 (11), p.1802-1808

2019

Volltextzugriff (PDF)

Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years

JAMA internal medicine, 2013-09, Vol.173 (17), p.1629

2013

Volltextzugriff (PDF)

Bisphosphonate Use and Breast Cancer Risk among Women with Ductal Carcinoma In Situ

Cancer research (Chicago, Ill.), 2021-05, Vol.81 (10), p.2799-2802

2021

Volltextzugriff (PDF)

Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women

Cancer epidemiology, biomarkers & prevention, 2016-09, Vol.25 (9), p.1297-1304

2016

Volltextzugriff (PDF)

Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer

Clinical cancer research, 2021-06, Vol.27 (11), p.3079-3093

2021

Volltextzugriff (PDF)

Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer

Breast cancer research and treatment, 2016-06, Vol.157 (3), p.545-554

2016

Volltextzugriff (PDF)

Determinants of Guideline-Discordant Breast Cancer Care

Cancer epidemiology, biomarkers & prevention, 2021-01, Vol.30 (1), p.61-70

2021

Volltextzugriff (PDF)

Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ

Breast cancer research and treatment, 2022-06, Vol.193 (2), p.477-484

2022

Volltextzugriff (PDF)

Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer

Cancer causes & control, 2021-12, Vol.32 (12), p.1375-1384

2021

Volltextzugriff (PDF)

Family History and Risk of Second Primary Breast Cancer after In Situ Breast Carcinoma

Cancer epidemiology, biomarkers & prevention, 2018-03, Vol.27 (3), p.315-320

2018

Volltextzugriff (PDF)

Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma

Cancer causes & control, 2019-01, Vol.30 (1), p.113-120

2019

Volltextzugriff (PDF)

Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer

Discover. Oncology, 2019-06, Vol.10 (2-3), p.71-76

2019

Volltextzugriff (PDF)

Antihypertensive medications and breast cancer risk-reply

JAMA internal medicine, 2014-04, Vol.174 (4), p.641

2014

Volltextzugriff (PDF)

Bisphosphonate Use After Estrogen Receptor-Positive Breast Cancer and Risk of Contralateral Breast Cancer

JNCI : Journal of the National Cancer Institute, 2011-12, Vol.103 (23), p.1752-1760

2011

Volltextzugriff (PDF)

Adjuvant Hormonal Therapy for Breast Cancer and Risk of Hormone Receptor―Specific Subtypes of Contralateral Breast Cancer

Cancer research (Chicago, Ill.), 2009-09, Vol.69 (17), p.6865-6870

2009

Volltextzugriff (PDF)

A Case-Control Study of Ovarian Cancer in Relation to Infertility and the Use of Ovulation-inducing Drugs

American journal of epidemiology, 2004-12, Vol.160 (11), p.1070-1078

2004

Volltextzugriff (PDF)

Relationship between diabetes and risk of second primary contralateral breast cancer

Breast cancer research and treatment, 2011-01, Vol.125 (2), p.545-551

2011

Volltextzugriff (PDF)

Relationship Between Anthropometric Factors and Risk of Second Breast Cancer Among Women With a History of Ductal Carcinoma In Situ

JNCI cancer spectrum, 2018-04, Vol.2 (2), p.pky020-pky020

2018

Volltextzugriff (PDF)

Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women’s Contraceptive and Reproductive Experiences Study

Fertility and sterility, 2003-04, Vol.79 (4), p.844-851

2003

Volltextzugriff (PDF)

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

JAMA : the journal of the American Medical Association, 2003-06, Vol.289 (24), p.3254

2003

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Female
(28)
Humans
(28)
Oncology
(28)
Case-Control Studies
(20)
Risk Factors
(19)
Breast Neoplasms - Epidemiology
(17)
Adult
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Middle Aged
(15)
Public, Environmental & Occupational Health
(15)
Aged
(14)
Breast Cancer
(14)
Tumors
(14)
Gynecology. Andrology. Obstetrics
(13)
Mammary Gland Diseases
(12)
Odds Ratio
(10)
Epidemiology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Active smoking and the risk of estrogen receptor‐positive and triple‐negative breast cancer among women ages 20 to 44 years

Relationship Between Potentially Modifiable Lifestyle Factors and Risk of Second Primary Contralateral Breast Cancer Among Women Diagnosed With Estrogen Receptor–Positive Invasive Breast Cancer

Height, body mass index (BMI), BMI change, and the risk of estrogen receptor‐positive, HER2‐positive, and triple‐negative breast cancer among women ages 20 to 44 years

Disparities in Risk of Advanced-Stage Liver Cancer and Mortality by Race and Ethnicity

Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer

Relationship between Diabetes and Diabetes Medications and Risk of Different Molecular Subtypes of Breast Cancer

Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years

Bisphosphonate Use and Breast Cancer Risk among Women with Ductal Carcinoma In Situ

Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women

Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer

Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer

Determinants of Guideline-Discordant Breast Cancer Care

Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ

Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer

Family History and Risk of Second Primary Breast Cancer after In Situ Breast Carcinoma

Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma

Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer

Antihypertensive medications and breast cancer risk-reply

Bisphosphonate Use After Estrogen Receptor-Positive Breast Cancer and Risk of Contralateral Breast Cancer

Adjuvant Hormonal Therapy for Breast Cancer and Risk of Hormone Receptor―Specific Subtypes of Contralateral Breast Cancer

A Case-Control Study of Ovarian Cancer in Relation to Infertility and the Use of Ovulation-inducing Drugs

Relationship between diabetes and risk of second primary contralateral breast cancer

Relationship Between Anthropometric Factors and Risk of Second Breast Cancer Among Women With a History of Ductal Carcinoma In Situ

Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women’s Contraceptive and Reproductive Experiences Study

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

Suchergebnisse filtern